Find more information in our portfolio of scientific documents
Contact our Team
Early and Strategic Application of Advanced Analytics Can Improve Biologic Development, Manufacturing, and Clinical Outcomes Brochure

The strategic use of advanced analytics is an essential element in today’s early-stage product selection and development. This is particularly true for more complex biologics and emerging modalities such as gene therapy, gene editing, and structurally complex conjugated and fusion biologic products.

Analysis of kinetic stability of proteins by DSC Poster

Temperature-induced unfolding of monoclonal antibodies and other therapeutic proteins, analyzed by differential scanning calorimetry (DSC) is an indispensable tool for the identification of the candidates with the lowest tendency to denature or of the formulations that increase stability. These decisions usually take into account the thermodynamic stability, represented by the melting temperature (Tm) of the protein and enthalpy of unfolding, derived from equilibrium thermo-dynamic analysis. However, the temperature induced denaturation of proteins is rarely reversible and equilibrium…

Characterization of Protein Variants Detected by Capillary Gel Electrophoresis Webinar

Protein-based drugs are characterized with a plentitude of different analytical approaches and methods. Each of these methods provides insight into a certain aspect of the molecule. For example, capillary Gel Electrophoresis (cGE) provides detailed information about the relative impurity content and the purity of an analyte. Especially for low molecular weight species, cGE shows high resolving power and a reproducible relative quantification.

One of the key aspects is not simply just to quantify the different detected signals but also to identify if they originate from the drug…

Mass spectrometry for risk assessment in HCP control Webinar

Host Cell Proteins (HCP) are critical quality attributes and must be monitored during the manufacturing processes by an adequate control strategy.

Protagen Protein Services (PPS) developed an approach for qualitative and quantitative control of HCPs applying shotgun LC-MS. This approach enables us to gain knowledge about HCP level, clusters and species and allows for risk assessment in HCP control.

In this webinar, experts from PPS will discuss the USP and DSP parameters of four different biopharmaceutical products, two different process variants, and one mock…


The development of a biopharmaceutical consists of R&D, CMC manufacturing and clinical trial phases. The quality of the biopharmaceutical product and its assessment via biophysical and biochemical analysis are essential components of this process. The requirements for the protein content determination method are thus very strict, and there is an eminent need for high precision and accuracy. We present a concept for developing, qualifying and validating a precise, accurate and robust method for protein content determination, one that can be adapted to the specific requirements of the product…

Advanced HDX-MS Approaches for Target Binding Analysis in Biologics Development Brochure

Target engagement is a critical factor in drug efficacy. Understanding and controlling how drug candidates interact with their expected targets can be enhanced using combined profiling approaches, specifically high-resolution analyses that provide details about the interaction. Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) and Native Mass Spectrometry (Native MS) are powerful, information-rich approaches that are increasingly used for binding site profiling and analysis of stoichiometry.

Mass Spectrometry-based Host Cell Protein Analysis in Biologics Development Brochure

Host cell proteins (HCPs) are impurities present in all therapeutics derived from biological sources, and as a critical quality attribute (CQA), they must be characterized in detail and controlled through the manufacturing process and in the final drug product.

Advanced HDX-MS Native-MS Approaches for De-risked Biologic Candidate Selection and CMC Development Whitepaper

Despite substantial efforts utilizing a diverse set of biologic evaluation and highthroughput techniques to select candidates with the best chance of success in preclinical development, the vast majority of biologic drug molecules fail in clinical trials. With most biologic drugs, including gene therapies, failures are realized in late-stage development, after substantial investment has been made in a candidate. Here, we discuss the potential for improving identification of potentially successful biologic drugs and de-risking CMC and clinical designs earlier through strategic application of…

Advanced Analytical Approaches for Improved Development of Cell and Gene Therapies Brochure

Cell and gene therapies have the potential to provide long-term therapeutic efficacy, but their development is both risky and cost-intensive. Obtaining a better understanding of the specific structural attributes of vector proteins that influence clinical delivery and outcomes is essential for advancing both individual candidates and the platforms on which they are based.

Stability Testing Brochure

Stability programs are mostly conducted over several years. It is vital that all analytical techniques perform in a robust manner, in order to prevent out-of-specification (OOS), out-of-expectation (OOE), or out-of-trend results (OOT), which would put the study or a potential product release at risk. PPS qualifies and validates all applied methods, including a profound robustness assessment for critical methods (e.g. by DoE approaches).

I agree to be contacted and have read and accepted the TERMS OF USE and PRIVACY POLICY


See here our latest newsletter. The company is constantly informing in E-Mail about latest technology developments,
typical applications, as well as strategic approaches in biotherapeutic development.



Protagen Protein Services (PPS) is a world leading CRO and recognized expert for analytical services in protein science regarding characterization, method development, validation and routine testing of antibodies, proteins, vaccines and other formates of biopharmaceuticals. Our sites are equipped with modern, state-of-the-art equipment for the analytical characterization of biopharmaceuticals regarding structure, purity, chemical modification, aggregation, particle formation, thermal stability e.g.. We offer service modules for analytcal support from research to approval regarding:

  • Developability
  • Clone Selection & Process Development
  • Extendend Characterization & Comparability
  • Stability & Release